Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2010-03-22EMA Application withdrawn: Ratioepo (epoetin theta) — Ratiopharm GmbH
EMA withdrew the application for Ratioepo (epoetin theta) by Ratiopharm GmbH for anemia-related indications.
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation [Phase 1]
Phase 1 clinical trial evaluating the effects of Ashwagandha on stress, inflammation, and immune cell activation; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion [Phase 1]
Phase 1 study evaluating surgery followed by intrapleural docetaxel for malignant pleural effusion; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial from Denmark evaluating a psychosocial rehabilitation course for cancer survivors.
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies [Phase 2]
A Phase 2 trial evaluating fractionated dosing of darbepoetin alfa to treat anemia in subjects with non-myeloid malignancies has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: BMS-599626 in Patients With Advanced Solid Malignancies [Phase 1]
Phase 1 study of BMS-599626 in patients with advanced solid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer [Phase 1]
Phase I study evaluating daily-schedule oral taxane BMS-275183 in combination with esomeprazole in patients with advanced cancer. The trial …
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer [Phase 1]
A Phase I study evaluating a single dose of radio-labeled BMS-275183 in patients with advanced cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Safety and Feasibility of Fasting While Receiving Chemotherapy
This clinical trial evaluates the safety and feasibility of fasting during chemotherapy in cancer patients, focusing on tolerability and the…
-
CLINICAL_TRIALS research · 2010-02-25Clinical Trial Update: Improving the Sleep of Cancer Patients Using an Internet-Based Program [NA]
The document reports the completion of a clinical trial evaluating an internet-based program to improve sleep in cancer patients.
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Study of XL999 in Adults With Solid Tumors [Phase 1]
A Phase 1 study of XL999 in adults with solid tumors has completed. The update is sourced from ClinicalTrials.gov.
-
EMA safety_alert · 2010-02-18European Medicines Agency recommends contraindication for Regranex in patients with any pre-existing cancer
EMA recommends contraindicating Regranex (becaplermin) in patients with any pre-existing cancer.
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED) [Phase 1]
A Phase 1 crossover trial evaluating vorinostat in patients with advanced cancer has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain [Phase 3]
Phase 3 trial of oxymorphone extended-release for cancer-related and neuropathic pain has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study [Phase 2]
This phase 2 pilot study evaluates delta-9-tetrahydrocannabinol (Dronabinol) as an orexigenic therapy to improve appetite in advanced cancer…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases [Phase 1]
Phase 1 clinical trial update describing the use of Helical Tomotherapy as a radiotherapy technique to treat pelvic and abdominal metastases…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Spouses/Partners Expressing Their Thoughts After Transplant [NA]
This completed clinical trial update notes that spouses and partners shared their thoughts after hematopoietic stem cell transplantation for…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists [Phase 2]
This is a Phase 2 randomized discontinuation trial comparing lapatinib to placebo in cancer patients who progressed after chemotherapy or ha…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: PORTAS 2, Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port [NA]
A completed clinical trial (PORTAS 2) comparing two techniques for inserting a totally implantable port in cancer patients.
-
CLINICAL_TRIALS trial_result · 2010-01-22Clinical Trial Update: Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids [Phase 3]
This document reports the completion of a Phase 3 trial evaluating Nasalfent for breakthrough cancer pain in patients on regular opioids. It…
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Phase 3]
A Phase 3 clinical trial sponsored by Amgen evaluated treatment for anemia in patients with non-myeloid malignancies undergoing multicycle c…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemo- and/or Radiotherapy Induced Mucositis [NA]
A completed clinical trial assessed whether topical morphine mouthwash reduces oral pain in patients with chemotherapy- or radiotherapy-indu…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan [Phase 1]
Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with solid tumors; the trial has completed.
-
CLINICAL_TRIALS research · 2010-01-07Clinical Trial Update: Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
This completed clinical trial analyzes factors contributing to low patient accrual in cancer center trials at one academic institution versu…
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Destara (ibandronic acid) — Roche Registration Ltd.
Destara (ibandronic acid) has been withdrawn from the European market by Roche Registration Ltd., affecting indications in hypercalcemia and…